Publication | Open Access
KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer
35
Citations
0
References
2017
Year
Keynote-059 UpdateOncologyEsophageal CancerGastrointestinal OncologyPembrolizumab AloneGastroenterologyPathologyAdvanced GastricCancer TreatmentMedicineRadiation Oncology
No additional data available for this publication yet. Check back later!